| CN

Clinical Trials

Immunochina will endeavor and provide the high-quality service to
assist each patient to fight cancer. We sincerely wish all patients a speedy and sound recovery

Beijing Immunochina Pharmaceutical Co., Ltd. is currently conducting various CAR-T clinical trials for relapsed or refractory non-Hodgkin's lymphoma, multiple myeloma, liver cancer and pancreatic cancer. If you are interested in participation, please contact Mr. Wu at 010-62886890.

Drug Disease Subject's Description
IM19 relapsed or refractory non-Hodgkin's lymphoma  If you or your acquaintances are suffering from relapsed or refractory non-Hodgkin's lymphoma,
and are over 18 years old, feel free to contact us.
We will evaluate your situation and let you know if you are suitable for the IM19 therapy. 

If you would like more information, please contact us through the following ways:


Web: http://www.immunochina.com

Email: wufei@immunochina.com